Pharmaceutical composition comprising a combination of an antidepressant and anxiolytic agent for Control and Treatment of Depressive Disorders

摘要

The present Invention relates to a Pharmaceutical composition comprising a synergistic combination of an antidepressant Selective inhibitor of 5-ht uptake, as is the active Principle: sertraline and anxiolytic Agent belonging to the group of triazolobe Nzodiazepinas, as is the active Principle: alprazolam;Which are formulated in a Single Dose to be administered orally in the form of capsules or tablets, which is indicated for the treatment and Control of diseases such as: Depressive Disorders and related diseases.